NCT04214496View on ClinicalTrials.gov

Electroencephalographic Biomarker to Predict Acute Post-operatory Cognitive Dysfunction

CompletedOBSERVATIONAL
Enrollment

106

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

August 4, 2022

Study Completion Date

August 4, 2022

Conditions
Cognitive DysfunctionPostoperative Delirium
Interventions
DEVICE

Sedline

Intraoperative EEG monitorization

Trial Locations (2)

8380456

Hospital Clinico Universidad de Chile, Santiago

Unknown

Instituto Nacional del Cancer, Santiago

Sponsors

Collaborators (1)

Masimo Corporation
All Listed Sponsors
collaborator

Masimo Corporation

INDUSTRY

lead

University of Chile

OTHER

NCT04214496 - Electroencephalographic Biomarker to Predict Acute Post-operatory Cognitive Dysfunction | Biotech Hunter | Biotech Hunter